| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |